Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,037,548
-$904,374 QoQ
Shares Held
292,257
+3.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#503
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Edgemoor Investment Advisors, Inc. holds $32,892,585 across 7 Drug Manufacturers - General names. PFE ranks #3 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,032 | $13,232,112 | |
| 2 | NVS |
Novartis AG
|
52,824 | $8,278,577 | |
| 3 | PFE |
Pfizer Inc
This page
|
292,257 | $7,037,548 | |
| 4 | JNJ |
Johnson & Johnson
|
10,588 | $2,689,034 | |
| 5 | AMGN |
Amgen Inc
|
1,910 | $691,649 | |
| 6 | ABBV |
AbbVie Inc.
|
2,437 | $613,246 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,727 | $350,419 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,037,548 | 292,257 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $7,941,922 | 282,832 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,671,457 | 267,930 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,482,137 | 254,401 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,734,432 | 236,569 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $5,411,939 | 213,573 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $496,641 | 18,720 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $541,756 | 18,720 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $523,785 | 18,720 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $583,221 | 21,017 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $600,530 | 20,859 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $719,158 | 21,681 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $795,259 | 21,681 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $897,151 | 21,989 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,384,043 | 27,011 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,047,876 | 23,946 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,457,711 | 27,803 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,429,266 | 27,608 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,581,713 | 26,786 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,152,065 | 26,786 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,374,946 | 35,111 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,222,074 | 33,731 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,137,539 | 30,903 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,222,035 | 33,298 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $430,430 | 13,163 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $429,639 | 13,163 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||